Work Here?
Overview
Kintsugi Health develops voice biomarker technology to help healthcare providers screen for mental health issues. It analyzes short clips of speech to detect signs of depression and anxiety and licenses this technology to risk-bearing health systems to integrate into existing care workflows. The system processes speech through an AI model to generate clinician-facing insights that complement clinical judgment, not replace diagnosis. The company focuses on ethical AI, fairness, explainability, privacy, and regulatory compliance, and aims to make mental healthcare more accessible and equitable at scale.
About Kintsugi
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$22.2M
Headquarters
Berkeley, California
Founded
2019
Simplify's Take
What believers are saying
- Raised $26.5 million from 2020-2022 to fund voice biomarker advancements.
- Partners with Wellin5 and Dreavita integrate into Zoom and Epic EHR.
- Soft-launched Kintsugi Connect platform scales mental health access.
What critics are saying
- Closed operations February 2026, open-sourced all AI models.
- Sonde Health and Ellipsis Health replicate tech, capture market share.
- Founders Grace Chang, Rima Seiilova-Olson joined Ginger and Lyra Health.
What makes Kintsugi unique
- Kintsugi Voice detects depression from 25-second speech clips with 71.3% sensitivity.
- Language-agnostic AI analyzes pitch, tone, pauses without content comprehension.
- Validated in double-blind study against SCID-5 for FDA De Novo submission.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$22.2M
Above
Industry Average
Funded Over
6 Rounds
Insight PartnersIndustry standards
Growth & Insights and Company News
6 month growth
↑ 11%1 year growth
↑ 11%2 year growth
↑ 11%Haritha joins Kintsugi Health with extensive experience in clinical operations, having previously led large-scale SaMD clinical trials as a Clinical Operations Lead at Apple.
Kintsugi receives Frost & Sullivan's 2024 Enabling Technology Leadership Award.
Kintsugi was named 2022 Gartner Cool Vendor in AI Governance and Responsible AI.
CARLSBAD, Calif.--(BUSINESS WIRE)--Wellin5, the premier provider of online counseling, proudly announces a new partnership with Kintsugi, an AI mental health technology leader. This collaboration comes at a time when Wellin5 has successfully navigated the turbulent economic landscape and challenges in the health tech space to thrive and bring this vital partnership to life, setting a new standard in mental health care for over 50,000 clients based in Canada and the USA. “We are immensely proud of this partnership with Kintsugi. It represents not just our resilience and growth in challenging times but also our commitment to innovative solutions in mental health care,” said William Masih, CEO and founder of Wellin5. “This collaboration will significantly enhance our ability to provide empathetic, effective, and data-driven care to our patients.”. Kintsugi's AI-powered tool, Kintsugi Voice, will be integrated into Wellin5’s counseling services, offering a revolutionary mental health screening and monitoring approach
AI mental health tech startup Kintsugi announces partnership with Wellin5.
There are no jobs for Kintsugi right now.
Find jobs on Simplify and start your career today
About Kintsugi
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
11-50
Company Stage
Series A
Total Funding
$22.2M
Headquarters
Berkeley, California
Founded
2019
There are no jobs for Kintsugi right now.
Find jobs on Simplify and start your career today